Pediatric Radiation Therapy Registry
NCT07129317 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2025-11-05
Summary
The Johns Hopkins Pediatric Radiation Oncology Program is creating a registry that will capture the full 3D radiation dosimetry delivered to its pediatric patients to manage the quality of care provided, as well as to examine the long-term outcomes and toxicity of each patient. The registry will capture baseline clinical data, disease, toxicity, and quality of life outcomes. The goal is to include all pediatric patients undergoing proton therapy and photon therapy to enable future comparisons of treatment outcomes.
Conditions
- Sarcoma
- Pediatric Brain Tumors
Sponsors & Collaborators
-
Clark Charitable Foundation Inc.
collaborator OTHER -
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
lead OTHER
Principal Investigators
-
Sahaja Acharya, MD · SKCCC Johns Hopkins Medical Institution
Eligibility
- Min Age
- 0 Years
- Max Age
- 26 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-31
- Primary Completion
- 2035-09-30
- Completion
- 2040-09-30
Countries
- United States
Study Locations
More Related Trials
-
Antibiotic Resistance in Global Pediatric Oncology Centers
NCT03721562 ·Status: COMPLETED
-
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
NCT00919750 ·Status: COMPLETED
-
Protocol For Collecting Data On Patients With Childhood Cancer
NCT00684580 ·Status: RECRUITING
-
LIFE Cancer Survivorship Database for Pediatric Cancer
NCT01518400 ·Status: RECRUITING
-
Therapy for Pediatric Hodgkin Lymphoma
NCT00145600 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
NCT00303810 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
NCT00025259 ·Status: COMPLETED ·Phase: PHASE3
-
Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors
NCT00313521 ·Status: UNKNOWN ·Phase: PHASE2
-
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors
NCT00001574 ·Status: COMPLETED
-
Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma
NCT00031590 ·Status: TERMINATED ·Phase: PHASE2
-
Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy
NCT02644993 ·Status: RECRUITING ·Phase: NA
-
Antineoplaston Therapy in Treating Children With Brain Tumors
NCT00003458 ·Status: COMPLETED ·Phase: PHASE2
-
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
NCT00003476 ·Status: TERMINATED ·Phase: PHASE2
-
Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
NCT00031577 ·Status: TERMINATED ·Phase: PHASE1
-
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
NCT00326664 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Imaging Changes Following Proton Therapy for Pediatric Primary Central Nervous System and Base of Skull Tumors
NCT04296617 ·Status: COMPLETED
-
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
NCT06624371 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Proton Therapy in Pediatric Cancer Patients
NCT03223766 ·Status: ACTIVE_NOT_RECRUITING
-
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
NCT00683319 ·Status: ACTIVE_NOT_RECRUITING
-
High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
NCT00180791 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
NCT00085735 ·Status: COMPLETED ·Phase: PHASE3
-
Validation Study of Pediatric Patient-Reported Outcomes
NCT03229837 ·Status: COMPLETED
-
Treatment for Classical Hodgkin Lymphoma in Children and Adolescents
NCT02797717 ·Status: RECRUITING ·Phase: NA
-
Therapy for Children With Advanced Stage Neuroblastoma
NCT01857934 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
NCT00749723 ·Status: COMPLETED ·Phase: PHASE2/PHASE3